While they have similar function, SCN2A is expressed earlier in development than SCN8A, which explains the earlier age of onset in SCN2A‐related epilepsies (median = 13 days), compared to SCN8A patients (median = 4 months; Brunklaus et al., 2020). The gene discussed is SCN8A; the disease is epilepsy.